greeksoup/ stocks
Stocks / United States / CI · Hospital & Medical Service Plans · NYSE

Cigna Group (CI)

Compare with another name

Cigna Group (CI) reported revenue of $71.7 billion for Q2 FY2026, the quarter ended 30 June 2026, up 6.7% on the same quarter a year earlier. Net income was $1.7 billion, up 8.4% on the year, and diluted earnings per share $6.29. The figures are the company's own, from the 10-Q it filed with the SEC on 30 July 2026.

Revenue$71.7 billionup 6.7%
Net income$1.7 billionup 8.4%
Diluted EPS$6.29
QuarterQ2 FY2026ended 30 June 2026

Ratios

From the filings

ROE15.1%
ROCE13.9%
Operating margin3.5%
Net margin2.3%
FCF marginn/a
Interest cover7.03
Debt to equity0.68
Cash conversion1.60
Share count, 1 year-1.0%
Sales CAGR, 3 years15.0%
Profit CAGR, 3 years-3.9%
EPS, TTM$24.17

At the close of 21 September 2026

Price$274.47
Market cap$72.5 billion
Stock P/E11.36
Price to book1.70
EV / EBITDA7.52
Dividend yield2.2%
Market cap / sales0.26
52-week high$311.00
52-week low$244.41
Price, 1 year-5.5%
Price CAGR, 3 years-1.8%
Price CAGR, 5 years6.3%

Every figure is arithmetic on the filed lines (hover a name for the formula); the priced ones use the latest daily close, CBOE delayed quotes, daily history, by CBOE, for splits. Debt to equity here stands on the one borrowings figure Cigna Group files, which has finance leases inside it; operating leases are a separate line. Nothing here is a valuation or a view.

Price, 17 September 2021 to 21 September 2026

Daily closes from CBOE delayed quotes, daily history, by CBOE, for splits; the last is 21 September 2026. P/E is the close over the trailing four quarters' EPS as filed at each filing date, on the current share count; the dashed line is the median over the range shown. Sales and margin are quarterly revenue and the operating margin from the tables above. EV/EBITDA, price to book and market cap to sales use the latest filed balance sheet and share count at each date. Drawn in your browser; the range and overlay you pick are remembered here only.

The public record on CI

Filings18 in twelve months: 10 current reports (8-K), about 4 results of operations; 3 regulation fd disclosure; 2 officer or director change; 1 shareholder vote; 1 other events
Planned insider sales9 Form 144 notices in twelve months, $70.2 million; latest 3 September 2026
Options tapeput/call 1.93 by open interest on 23 September 2026; the straddle prices a 2.3% move to 25 September 2026
Holders11 of the followed funds hold it; largest Dodge & Cox; 4 Schedule 13D or 13G filings in twelve months
Insider trading20 sales and 1 purchase on Form 4 in twelve months
Congress4 House trades disclosed in six months
Short interest6.3 million shares short, 4.55 days to cover at 31 August 2026
Documentsthe 10-K, the 10-Qs, the proxy and 4 earnings press releases, each linked

Quarterly results, the last 12 quarters

Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026
Revenue49,04851,11457,25560,52363,69465,64965,50267,17869,74872,47268,49471,668
Cost of revenue33,63935,26141,43144,49247,56549,02148,39853,26855,53057,79554,10056,703
Gross profit15,40915,85315,82416,03116,12916,62817,10413,91014,21814,67714,39414,965
Gross margin31%31%28%26%25%25%26%21%20%20%21%21%
SG&A3,7884,0623,7053,6843,5903,8654,2133,4333,3623,6093,7223,470
Operating income2,2402,0602,2562,4122,5762,1731,9712,3062,5782,3452,3582,676
Operating margin5%4%4%4%4%3%3%3%4%3%3%4%
Interest expense353352369378380373362338363337357359
Pre-tax income1,84018879.01,9891,1922,0091,6482,0212,2951,8172,2702,257
Tax rate21%-489%368%18%31%24%15%19%14%30%18%17%
Net income1,4081,029-2771,5487391,4241,3231,5321,8681,2341,6541,660
Net margin3%2%-0%3%1%2%2%2%3%2%2%2%
Diluted EPS$4.74$3.49-$0.97$5.45$2.63$5.01$4.85$5.71$6.98$4.64$6.26$6.29
Operating cash flow2,8261,4674,84026546.05,2121,920-1,8863,4186,1491,131-421
Buybacks6245444,0229900.02,0221,5081,1120.01,0010.0280
Dividends paid362358401392390384412401402396417409
Shares outstanding293m293m284m280m278m274m267m267m267m263m265m264m
Filing10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q

* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Profit and loss, 10 fiscal years and the trailing twelve months

FY2016FY2017FY2018FY2019FY2020FY2021 FY2022 FY2023FY2024FY2025TTM
Revenue39,83841,80648,650153,566160,401174,078180,516195,265247,121274,900282,382
Cost of revenue2,4682,4564,79397,668103,484117,553124,834133,801182,509214,991224,128
Gross profit37,37039,35043,85755,89856,91756,52555,68261,46464,61259,90958,254
Gross margin93.8%94.1%90.1%36.4%35.5%32.5%30.8%31.5%26.1%21.8%20.6%
Selling, general and administrative9,79010,03011,93414,05314,07213,03013,18614,82214,84414,61714,163
Operating income3,0883,9424,1608,0778,1537,9358,4508,5369,4179,2009,957
Operating margin7.8%9.4%8.6%5.3%5.1%4.6%4.7%4.4%3.8%3.3%3.5%
Interest expense2512435071,6001,4001,3001,3001,4001,5001,4001,416
Pre-tax income2,9793,6063,5816,57010,8686,7828,3975,5135,2697,7818,639
Income tax1,1361,3749351,4502,3791,3701,6151411,4911,4931,656
Effective tax rate38.1%38.1%26.1%22.1%21.9%20.2%19.2%2.6%28.3%19.2%19.2%
Net income1,8672,2372,6375,1048,4585,3656,7045,1643,4345,9576,416
Net margin4.7%5.4%5.4%3.3%5.3%3.1%3.7%2.6%1.4%2.2%2.3%
Diluted EPS$7.19$8.77$10.54$13.44$22.96$15.73$21.30$17.39$12.12$22.18$24.17
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K

Income statement lines from each year's 10-K, the year linked to its filing; TTM is the sum of the last four quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are. † The year as the company last restated it in a later filing; rest on a figure for the one first filed. EPS is as filed.

Cash flow and capital returned

FY2016FY2017FY2018FY2019FY2020FY2021 FY2022 FY2023FY2024FY2025TTM
Operating cash flow4,0264,0863,7709,48510,3507,1918,65611,81310,3639,60110,277
Capital expenditure4614715281,050n/an/an/an/an/an/an/a
Free cash flow3,5653,6153,2428,435n/an/an/an/an/an/an/a
Free cash flow margin8.9%8.6%6.7%5.5%n/an/an/an/an/an/an/a
Depreciation and amortisation6105666953,6512,8022,9232,9373,0352,7752,7752,724
Share-based compensation128178180299289268264286308291n/a
Buybacks1392,7253421,9874,0427,7427,6072,2847,0343,6211,281
Dividends paidn/an/an/a15.015.01,3411,3841,4501,5671,6111,624
Dividend per sharen/a$0.04$0.04$0.04$0.04$4.00$4.48$4.92$5.60$6.04n/a
Diluted shares, weighted260m255m250m380m368m341m313m297m283m269m264m
Shares outstanding at period end0m0m381m373m355m323m299m293m274m263m264m
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K

Buybacks and dividends are the cash paid in the year, from the cash flow statement; the dividend per share is as declared. Diluted shares are the weighted average for the year; a falling count is the buybacks net of issuance. TTM sums the last four quarters; the share counts are the latest quarter's.

Balance sheet at year end

FY2016FY2017FY2018FY2019FY2020FY2021 FY2022 FY2023FY2024FY2025TTM
Total assetsn/a61,759153,226155,774155,451154,889143,932152,761155,881157,919157,082
Cash and equivalents3,1852,9723,8554,61910,1825,0815,9247,8227,5507,6766,298
Receivablesn/a3,15510,47310,71612,19115,07117,21817,72224,22728,76830,800
Inventoryn/a2282,8212,6613,1653,7224,7775,6456,6927,3385,847
Goodwill5,9806,16444,50544,60244,64845,81145,81144,25944,37044,92445,534
Long-term debtn/an/a39,523n/an/an/an/an/an/an/an/a
Long-term debt including finance leasesn/a5,19939,52331,89329,54531,12528,10028,15528,93730,87129,086
Operating lease liabilitiesn/an/an/a465491n/a346340n/an/an/a
Finance lease liabilitiesn/an/a32.061.036.028.066.066.041.068.0n/a
Shareholders' equity13,70313,71141,02845,33850,32147,11244,67546,22341,03341,71342,620
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K

At the fiscal year end; the TTM column is the latest quarter end. A line the company does not tag under the usual name is left out.

Compounded growth

10 years5 years3 yearsTTM
Sales growth, compoundedn/a11.4%15.0%7.8%
Profit growth, compoundedn/a-6.8%-3.9%27.9%
Return on equity, average12.5%12.0%11.3%14.3%

Compounded growth is the latest fiscal year over the year that many years earlier, annualised; the TTM column is the last four quarters over the four before. Return on equity is net income over shareholders' equity at each year end, averaged over the window (the TTM column is the latest year alone); equity is the parent's shareholders' equity as tagged in the 10-K. Arithmetic on filed numbers, nothing forecast.

Peers: Hospital & Medical Service Plans

CompanyMarket capP/EROEOp. marginSales growth
TTM
Debt to equityDiv. yield
UnitedHealth Group Inc. UNH$341.7 billion24.2913.5%4.8%6.5%0.672.3%
Elevance Health, Inc. ELV$88.8 billion18.1211.1%2.7%6.3%0.691.7%
Cigna Group CI$72.5 billion11.3615.1%3.5%7.8%0.682.2%
Humana Inc. HUM$45.5 billion40.406.1%1.8%14.1%0.660.9%
Centene Corp. CNC$32.1 billionn/a-22.6%-2.8%13.9%0.71n/a

The names on this site in the same industry (the SEC's SIC description), by market capitalisation. Each figure is the same arithmetic as the ratio box above, on each company's own filings and latest close.

Filings

FilingPeriodFiledWhere
10-Q30 June 202630 July 2026EDGAR
10-Q31 March 202630 April 2026EDGAR
10-K31 December 202526 February 2026EDGAR
10-Q30 September 202530 October 2025EDGAR
10-Q30 June 202531 July 2025EDGAR
10-Q31 March 20252 May 2025EDGAR
10-K31 December 202427 February 2025EDGAR
10-Q30 September 202431 October 2024EDGAR
10-Q30 June 20241 August 2024EDGAR
10-Q31 March 20242 May 2024EDGAR

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install